Select Medical Holdings Corporation (SEM) To Go Ex-Dividend on March 2nd

Select Medical Holdings Corporation (NYSE:SEM) announced a quarterly dividend on Thursday, February 12th. Stockholders of record on Monday, March 2nd will be paid a dividend of 0.0625 per share by the health services provider on Thursday, March 12th. This represents a c) dividend on an annualized basis and a dividend yield of 1.7%. The ex-dividend date is Monday, March 2nd.

Select Medical has a dividend payout ratio of 19.1% meaning its dividend is sufficiently covered by earnings. Research analysts expect Select Medical to earn $1.41 per share next year, which means the company should continue to be able to cover its $0.25 annual dividend with an expected future payout ratio of 17.7%.

Select Medical Price Performance

NYSE SEM traded up $0.02 during mid-day trading on Friday, hitting $14.94. The stock had a trading volume of 916,343 shares, compared to its average volume of 974,834. The firm’s 50 day moving average is $15.28 and its 200 day moving average is $14.16. The company has a debt-to-equity ratio of 0.89, a current ratio of 1.04 and a quick ratio of 1.04. The stock has a market capitalization of $1.85 billion, a price-to-earnings ratio of 12.99, a PEG ratio of 0.85 and a beta of 1.25. Select Medical has a twelve month low of $11.65 and a twelve month high of $18.60.

Select Medical (NYSE:SEM) last released its earnings results on Thursday, February 19th. The health services provider reported $0.16 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.23 by ($0.07). The business had revenue of $1.40 billion for the quarter, compared to analysts’ expectations of $1.36 billion. Select Medical had a return on equity of 7.26% and a net margin of 2.68%.Select Medical’s quarterly revenue was up 6.4% compared to the same quarter last year. During the same period in the previous year, the company earned $0.18 EPS. Select Medical has set its FY 2026 guidance at 1.220-1.320 EPS. Equities research analysts forecast that Select Medical will post 1.17 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on the company. Royal Bank Of Canada cut their price target on Select Medical from $20.00 to $19.00 and set an “outperform” rating for the company in a report on Monday. Zacks Research lowered Select Medical from a “hold” rating to a “strong sell” rating in a report on Thursday. Weiss Ratings raised shares of Select Medical from a “sell (d+)” rating to a “hold (c-)” rating in a report on Friday, February 20th. Wall Street Zen downgraded shares of Select Medical from a “buy” rating to a “hold” rating in a research note on Saturday, February 21st. Finally, Mizuho set a $17.00 price target on shares of Select Medical in a research note on Monday, November 3rd. Four equities research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $16.25.

Select Medical Company Profile

Select Medical is a leading provider of specialized healthcare services in the United States, operating through two primary business segments: Hospital Division and Outpatient Rehabilitation Division. The Hospital Division offers long-term acute care (LTAC) hospitals and inpatient rehabilitation facilities (IRFs) that serve patients recovering from complex illnesses, trauma or surgery. The Outpatient Rehabilitation Division delivers physical, occupational and speech therapy services through a network of clinic locations and home-based care programs.

Headquartered in Mechanicsburg, Pennsylvania, Select Medical was founded in 1996 and has grown through strategic partnerships, joint ventures and acquisitions.